akeso
-
Health & Wellness
FDA Rejects Summit Therapeutics and Akeso Lung Cancer Drug Ivonescimab Over Lack of Survival Benefit
The Food and Drug Administration has officially rejected the marketing application for ivonescimab, a promising but controversial bispecific antibody designed…
Read More »